Início › Câncer de Bexiga › Arkansas
Ensaios clínicos de Câncer de Bexiga em Arkansas
15 estudos para Câncer de Bexiga estão buscando participantes em locais em Arkansas.
Cidades em Arkansas
Texto oficial do estudo (Inglês)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Highlands Oncology Group - Fayetteville, Fayetteville
- Highlands Oncology Group - Rogers, Rogers
- Highlands Oncology Group, Springdale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06770582Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Highlands Oncology Group - Fayetteville, Fayetteville
- Highlands Oncology Group - Rogers, Rogers
- Highlands Oncology Group, Springdale
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07061964Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Highlands Oncology Group, PA, Fayetteville
- Highlands Oncology Group, PA, Rogers
- Highlands Oncology Group, PA, Springdale
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07421700A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Arkansas for Medical Sciences, Little Rock
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- University of Arkansas for Medical Sciences, Little Rock
- Arkansas Urology, Little Rock
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Arkansas Urology, Little Rock
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
- Arkansas Urology, Little Rock
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT07480356Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Mercy Hospital Fort Smith, Fort Smith
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07097142LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Arkansas Urology, Little Rock
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Hot Springs
- Research Site, Little Rock
- Research Site, Little Rock
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07720284A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT04389632Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Mercy Hospital - FTS, Fort Smith
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07327489Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
- Arkansas Urology Research Center, Little Rock
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT05982561SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.